Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 23667681)

1.

VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice.

Damsker JM, Dillingham BC, Rose MC, Balsley MA, Heier CR, Watson AM, Stemmy EJ, Jurjus RA, Huynh T, Tatem K, Uaesoontrachoon K, Berry DM, Benton AS, Freishtat RJ, Hoffman EP, McCall JM, Gordish-Dressman H, Constant SL, Reeves EK, Nagaraju K.

PLoS One. 2013 May 7;8(5):e63871. doi: 10.1371/journal.pone.0063871. Print 2013.

2.

VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.

Reeves EK, Hoffman EP, Nagaraju K, Damsker JM, McCall JM.

Bioorg Med Chem. 2013 Apr 15;21(8):2241-9. doi: 10.1016/j.bmc.2013.02.009. Epub 2013 Feb 18.

3.

VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis.

Dillingham BC, Knoblach SM, Many GM, Harmon BT, Mullen AM, Heier CR, Bello L, McCall JM, Hoffman EP, Connor EM, Nagaraju K, Reeves EK, Damsker JM.

Cell Mol Neurobiol. 2015 Apr;35(3):377-87. doi: 10.1007/s10571-014-0133-y. Epub 2014 Nov 13.

PMID:
25392236
4.

Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation.

Lindner I, Meier C, Url A, Unger H, Grassauer A, Prieschl-Grassauer E, Doerfler P.

BMC Immunol. 2010 May 21;11:24. doi: 10.1186/1471-2172-11-24.

5.
6.

Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.

Yuda H, Adachi Y, Taguchi O, Gabazza EC, Hataji O, Fujimoto H, Tamaki S, Nishikubo K, Fukudome K, D'Alessandro-Gabazza CN, Maruyama J, Izumizaki M, Iwase M, Homma I, Inoue R, Kamada H, Hayashi T, Kasper M, Lambrecht BN, Barnes PJ, Suzuki K.

Blood. 2004 Mar 15;103(6):2196-204. Epub 2003 Nov 6.

7.

Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease.

Salter M, Biggadike K, Matthews JL, West MR, Haase MV, Farrow SN, Uings IJ, Gray DW.

Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L660-7. Epub 2007 Jun 15.

8.

Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.

Shimizu K, Konno S, Ozaki M, Umezawa K, Yamashita K, Todo S, Nishimura M.

Clin Exp Allergy. 2012 Aug;42(8):1273-81. doi: 10.1111/j.1365-2222.2012.04007.x.

PMID:
22805475
9.

Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway.

Cheng C, Ho WE, Goh FY, Guan SP, Kong LR, Lai WQ, Leung BP, Wong WS.

PLoS One. 2011;6(6):e20932. doi: 10.1371/journal.pone.0020932. Epub 2011 Jun 9.

10.

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.

Heier CR, Damsker JM, Yu Q, Dillingham BC, Huynh T, Van der Meulen JH, Sali A, Miller BK, Phadke A, Scheffer L, Quinn J, Tatem K, Jordan S, Dadgar S, Rodriguez OC, Albanese C, Calhoun M, Gordish-Dressman H, Jaiswal JK, Connor EM, McCall JM, Hoffman EP, Reeves EK, Nagaraju K.

EMBO Mol Med. 2013 Oct;5(10):1569-85. doi: 10.1002/emmm.201302621. Epub 2013 Sep 9.

11.

Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.

Kim SH, Hong JH, Lee YC.

Eur J Pharmacol. 2013 Feb 15;701(1-3):131-43. doi: 10.1016/j.ejphar.2012.11.033. Epub 2012 Nov 28.

PMID:
23201068
12.

A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

Ziegelbauer K, Gantner F, Lukacs NW, Berlin A, Fuchikami K, Niki T, Sakai K, Inbe H, Takeshita K, Ishimori M, Komura H, Murata T, Lowinger T, Bacon KB.

Br J Pharmacol. 2005 May;145(2):178-92.

13.

Astragalus extract attenuates allergic airway inflammation and inhibits nuclear factor κB expression in asthmatic mice.

Yang ZC, Qu ZH, Yi MJ, Wang C, Ran N, Xie N, Fu P, Feng XY, Lv ZD, Xu L.

Am J Med Sci. 2013 Nov;346(5):390-5. doi: 10.1097/MAJ.0b013e3182753175.

PMID:
23267235
14.

Xiao-Qing-Long-Tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model.

Wang SD, Lin LJ, Chen CL, Lee SC, Lin CC, Wang JY, Kao ST.

J Ethnopharmacol. 2012 Jul 13;142(2):531-8. doi: 10.1016/j.jep.2012.05.033. Epub 2012 Jun 1.

PMID:
22658987
15.

Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation.

El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC.

Int Immunopharmacol. 2006 Jul;6(7):1135-42. Epub 2006 Mar 2.

PMID:
16714217
16.

Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma.

Sagar S, Morgan ME, Chen S, Vos AP, Garssen J, van Bergenhenegouwen J, Boon L, Georgiou NA, Kraneveld AD, Folkerts G.

Respir Res. 2014 Apr 16;15:46. doi: 10.1186/1465-9921-15-46.

17.

Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-beta1 in an extended subacute mouse model of allergic asthma.

Mabalirajan U, Aich J, Agrawal A, Ghosh B.

Am J Physiol Lung Cell Mol Physiol. 2009 Sep;297(3):L411-9. doi: 10.1152/ajplung.00138.2009. Epub 2009 Jun 19.

19.

Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-κB activation in a mouse model of allergic asthma.

Ci X, Chu X, Xu X, Li H, Deng X.

Inflamm Res. 2012 Jul;61(7):749-58. doi: 10.1007/s00011-012-0470-6. Epub 2012 Apr 6.

PMID:
22481373
20.

Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB.

Goh FY, Upton N, Guan S, Cheng C, Shanmugam MK, Sethi G, Leung BP, Wong WS.

Eur J Pharmacol. 2012 Mar 15;679(1-3):109-16. doi: 10.1016/j.ejphar.2012.01.002. Epub 2012 Jan 20.

PMID:
22290391
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk